Field & Main Bank’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $887K | Sell |
1,805
-72
| -4% | -$39.1K | 0.26% | 77 |
|
|
2025
Q4 | $1.09M | Sell |
1,877
-45
| -2% | -$25.4K | 0.31% | 71 |
|
|
2025
Q3 | $932K | Buy |
1,922
+138
| +8% | +$64.2K | 0.28% | 78 |
|
|
2025
Q2 | $723K | Buy |
1,784
+80
| +5% | +$33.4K | 0.24% | 83 |
|
|
2025
Q1 | $848K | Sell |
1,704
-19
| -1% | -$10.3K | 0.3% | 77 |
|
|
2024
Q4 | $896K | Sell |
1,723
-245
| -12% | -$135K | 0.32% | 72 |
|
|
2024
Q3 | $1.22M | Buy |
1,968
+9
| +0.5% | +$5.33K | 0.43% | 60 |
|
|
2024
Q2 | $1.08M | Buy |
1,959
+41
| +2% | +$23.5K | 0.41% | 63 |
|
|
2024
Q1 | $1.11M | Buy |
1,918
+133
| +7% | +$74.6K | 0.43% | 64 |
|
|
2023
Q4 | $947K | Buy |
1,785
+79
| +5% | +$38.2K | 0.4% | 65 |
|
|
2023
Q3 | $863K | Sell |
1,706
-58
| -3% | -$30.9K | 0.4% | 64 |
|
|
2023
Q2 | $920K | Buy |
1,764
+9
| +0.5% | +$4.86K | 0.51% | 61 |
|
|
2023
Q1 | $1.01M | Buy |
1,755
+80
| +5% | +$45.1K | 0.6% | 55 |
|
|
2022
Q4 | $922K | Buy |
1,675
+30
| +2% | +$15.9K | 0.59% | 53 |
|
|
2022
Q3 | $834K | Sell |
1,645
-33
| -2% | -$18.5K | 0.56% | 56 |
|
|
2022
Q2 | $912K | Sell |
1,678
-5
| -0.3% | -$2.75K | 0.59% | 52 |
|
|
2022
Q1 | $994K | Sell |
1,683
-45
| -3% | -$25.9K | 0.6% | 51 |
|
|
2021
Q4 | $1.15M | Sell |
1,728
-15
| -0.9% | -$9.37K | 0.66% | 47 |
|
|
2021
Q3 | $996K | Sell |
1,743
-183
| -10% | -$100K | 0.66% | 50 |
|
|
2021
Q2 | $972K | Buy |
1,926
+55
| +3% | +$26K | 0.62% | 54 |
|
|
2021
Q1 | $854K | Buy |
1,871
+118
| +7% | +$56.3K | 0.61% | 55 |
|
|
2020
Q4 | $816K | Sell |
1,753
-450
| -20% | -$211K | 0.61% | 53 |
|
|
2020
Q3 | $973K | Sell |
2,203
-190
| -8% | -$78.5K | 0.75% | 43 |
|
|
2020
Q2 | $867K | Buy |
+2,393
| New | +$802K | 0.74% | 47 |
|
|
2019
Q4 | $824K | Buy |
2,538
+5
| +0.2% | +$1.52K | 0.68% | 51 |
|
|
2019
Q3 | $738K | Sell |
2,533
-35
| -1% | -$10K | 0.67% | 52 |
|
|
2019
Q2 | $754K | Buy |
2,568
+53
| +2% | +$14.6K | 0.69% | 49 |
|
|
2019
Q1 | $688K | Buy |
+2,515
| New | +$626K | 0.65% | 50 |
|
|
2018
Q3 | $654K | Sell |
2,680
-90
| -3% | -$20.7K | 0.58% | 55 |
|
|
2018
Q2 | $650K | Sell |
2,770
-86
| -3% | -$18.3K | 0.59% | 57 |
|
|
2018
Q1 | $590K | Sell |
2,856
-30
| -1% | -$6.3K | 0.58% | 58 |
|
|
2017
Q4 | $548K | Buy |
+2,886
| New | +$553K | 0.53% | 67 |
|
|
2015
Q2 | $698K | Sell |
5,380
-225
| -4% | -$29.3K | 0.66% | 59 |
|
|
2015
Q1 | $753K | Sell |
5,605
-550
| -9% | -$70.9K | 0.7% | 57 |
|
|
2014
Q4 | $771K | Sell |
6,155
-625
| -9% | -$76K | 0.72% | 54 |
|
|
2014
Q3 | $825K | Buy |
6,780
+75
| +1% | +$9.12K | 0.78% | 57 |
|
|
2014
Q2 | $791K | Buy |
6,705
+100
| +2% | +$11.8K | 0.74% | 60 |
|
|
2014
Q1 | $794K | Sell |
6,605
-553
| -8% | -$65.7K | 0.77% | 58 |
|
|
2013
Q4 | $797K | Buy |
+7,158
| New | +$712K | 0.78% | 60 |
|
Other funds holding TMO
VCM
Field & Main Bank's TMO Position: Q1 2026 in Review
Field & Main Bank reduced its Thermo Fisher Scientific (TMO) stake by 3.8% in Q1 2026, selling an estimated $39.1K and leaving 1,805 shares worth $887K. The position accounts for 0.26% of the portfolio, ranked #77.
Field & Main Bank first reported a position in TMO in Q4 2013 and has held it in 39 quarters since. The position peaked at $1.22M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Field & Main Bank held 1,805 shares of Thermo Fisher Scientific worth $887K as of Q1 2026.
- Field & Main Bank sold 72 Thermo Fisher Scientific shares in Q1 2026, an estimated $39.1K.
- Thermo Fisher Scientific made up 0.26% of Field & Main Bank's portfolio in Q1 2026, its #77 holding.
- Field & Main Bank first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 39 quarters since.
- Field & Main Bank's Thermo Fisher Scientific position peaked at $1.22M in Q3 2024.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Field & Main Bank's 13F filing for Q1 2026, filed 10 Apr 2026.